PL441229A1 - Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwych - Google Patents
Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwychInfo
- Publication number
- PL441229A1 PL441229A1 PL441229A PL44122922A PL441229A1 PL 441229 A1 PL441229 A1 PL 441229A1 PL 441229 A PL441229 A PL 441229A PL 44122922 A PL44122922 A PL 44122922A PL 441229 A1 PL441229 A1 PL 441229A1
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- methods
- compositions containing
- synthetic peptides
- malignant gliomas
- Prior art date
Links
- 206010018338 Glioma Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Przedmiotem zgłoszenia są zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania do leczenia nowotworów infiltrowanych makrofagami, takich jak złośliwe glejaki.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL441229A PL441229A1 (pl) | 2022-05-19 | 2022-05-19 | Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwych |
PCT/IB2023/055089 WO2023223241A1 (en) | 2022-05-19 | 2023-05-17 | Engineered synthetic peptides, compositions comprising same, and methods of use thereof for treating malignant gliomas |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL441229A PL441229A1 (pl) | 2022-05-19 | 2022-05-19 | Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwych |
Publications (1)
Publication Number | Publication Date |
---|---|
PL441229A1 true PL441229A1 (pl) | 2023-11-20 |
Family
ID=87136749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL441229A PL441229A1 (pl) | 2022-05-19 | 2022-05-19 | Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwych |
Country Status (2)
Country | Link |
---|---|
PL (1) | PL441229A1 (pl) |
WO (1) | WO2023223241A1 (pl) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS53782B1 (en) * | 2008-10-01 | 2015-06-30 | Immatics Biotechnologies Gmbh | TUMOR-ASSOCIATED PEPTIDES PREPARED AND ANTI-CHANGE RESPONSE FOR GLIOBLASTOMA (GBM) AND OTHER CANCER TREATMENTS |
EP2780363B1 (en) * | 2011-11-17 | 2019-07-03 | Glia SP Z.O.O. | Compositions and methods for treating glioma |
EP3886888A4 (en) * | 2018-11-28 | 2022-09-28 | Glia Sp. z o.o. | COMPOSITIONS AND METHODS FOR TREATING GLIOMA |
-
2022
- 2022-05-19 PL PL441229A patent/PL441229A1/pl unknown
-
2023
- 2023-05-17 WO PCT/IB2023/055089 patent/WO2023223241A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2023223241A1 (en) | 2023-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2019013001A2 (es) | Proteínas de anticuerpo injertadas con citocina y métodos de uso en el tratamiento del cáncer | |
BR112018008326A2 (pt) | composições e métodos para o tratamento de câncer | |
EA202092590A1 (ru) | Пиридазиноны в качестве ингибиторов parp7 | |
BR112018012756A2 (pt) | compostos heterocíclicos como imunomoduladores | |
EA201790248A1 (ru) | Композиции носитель-антитело и способы их получения и применения | |
WO2021007428A3 (en) | Molecules, compositions and methods for treatment of cancer | |
EA202191257A1 (ru) | Противораковая терапия на основе иммуноцитов, связывающих liv1 | |
EA201892075A1 (ru) | Комбинации ингибиторов lsd1 для применения для лечения солидных опухолей | |
MX2019010040A (es) | Composiciones y métodos para el tratamiento del cáncer. | |
PH12021550382A1 (en) | Tetrahydropyridopyrimidine derivatives as ahr modulators | |
TR201901077T4 (tr) | Kanser Veya Enfeksiyon Tedavisine Yönelik Birleşik Preparasyonlar | |
EA201790502A1 (ru) | Ингибиторы гистоновых диметилаз | |
MX344772B (es) | Analogos de estilbeno y metodos para tratar cancer. | |
BR112021015477A2 (pt) | Anticorpos anti-cd228 e conjugados anticorpo-fármaco | |
BR112022019020A2 (pt) | Proteínas de fusão de il12 mascaradas e métodos de uso das mesmas | |
MX2022000310A (es) | Inhibidores de proteina bcl-2. | |
PH12021551047A1 (en) | Anti-ptk7 immune cell cancer therapy | |
MX2019003077A (es) | Anticuerpos novedosos contra el factor xi y sus usos. | |
MX2021011524A (es) | Inhibidores de proteina arginina n-metiltransferasa 5 (prmt5) y usos de los mismos. | |
BR112022008821A2 (pt) | Ligantes de pseudoquinase tyk2 | |
MX2021008834A (es) | Metodos de tratamiento del cancer de mama con tucatinib. | |
ATE485059T1 (de) | Tumortherapie mit vektoren auf sindbis virus- basis | |
BR112018012884A2 (pt) | novos anticorpos anti-mmp16 e métodos de uso | |
WO2019016597A3 (en) | SYNTHETIC PROTEINS AND THEIR THERAPEUTIC USES | |
PL441229A1 (pl) | Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwych |